Comparison of Picosecond and Q-switched Laser for Benign Pigmented Lesions Treatment
Launched by MAHIDOL UNIVERSITY · Jun 10, 2016
Trial Information
Current as of June 25, 2025
Unknown status
Keywords
ClinConnect Summary
Benign pigmented lesions can be divided into epidermal lesions such as freckles, lentigines, solar lentigines or cafe au lait macules and dermal lesions such as Nevus of Ota or Hori's nevus.
Q-switched 532 and 1064 nm lasers were reported to be safe and effective in the treatment of these benign pigmented lesions. By using selective photothermolysis theory, both q-switched 532 and 1064 nm lasers target on melanin causes photomechanical destruction of the melanin. However, the occurrence of post inflammatory hyperpigmentation (PIH) were reported especially in patients with darker skin type....
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age \>18
- • having any benign pigmented lesions on both sides of the face or any tattoo on any part of body which would like to be removed
- • Fitzpatrick skin phototype 3-5
- Exclusion Criteria:
- • Previously treated with any laser within 3 months before enrollment into the study
- • Patients with lesions with any clinical suspicion of being pre-cancerous or skin malignancies of any kind
- • Patients who have photosensitive dermatoses
- • Pregnancy and lactation woman
- • Patients with wound infections (herpes, other) on the day of treatment
- • Patients with moderate and severe inflammatory acne, Immunosuppressed patients, history of vitiligo
- • Patients with unrealistic concerns/expectations and inability to do the appropriate post-operative care
About Mahidol University
Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, , Thailand
Patients applied
Trial Officials
Woraphong Manuskiatti, Prof., M.D.
Principal Investigator
Department of Dermatology, Siriraj Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials